Search results for "Cirrhosis"
Heart failure risk increased in patients with NAFLD, meta-analysis finds
Nonalcoholic fatty liver disease (NAFLD) was associated with a 50% increased risk of new-onset heart failure, independent of age, sex, diabetes, hypertension, and other common cardiovascular risk factors, according to an international meta-analysis.
https://gastroenterology.acponline.org/archives/2022/08/26/2.htm
26 Aug 2022
MKSAP Quiz: Follow-up after a diagnosis of primary sclerosing cholangitis
This month's quiz asks readers to determine the most appropriate management of a 34-year-old patient who presents to follow-up after receiving a diagnosis of primary sclerosing cholangitis.
https://gastroenterology.acponline.org/archives/2022/11/18/4.htm
18 Nov 2022
Best practices for HCV care include less invasive testing for many patients, says ACP
The College's new advice on treating hepatitis C virus (HCV) identifies patients who can be safely treated in primary care with laboratory monitoring limited to the beginning and end of treatment and no invasive testing.
https://gastroenterology.acponline.org/archives/2020/10/23/6.htm
23 Oct 2020
Spotlight on NAFLD outcomes
Recent studies found associations between nonalcoholic fatty liver disease (NAFLD) and coronary artery disease, sarcopenia, and mortality.
https://gastroenterology.acponline.org/archives/2022/05/27/5.htm
27 May 2022
HCV medications decreased liver disease among those using injection drugs
A Baltimore-based study found that half of participants with chronic hepatitis C virus (HCV) and a history of injection drug use at baseline were free of the virus by 2019, with associated reductions in their risk of cirrhosis and mortality.
https://gastroenterology.acponline.org/archives/2022/07/22/2.htm
22 Jul 2022
Spotlight on digestive risks of newer diabetes drugs
Recent studies linked the use of glucagon-like peptide-1 receptor agonists to risk of digestive diseases, such as acute cholecystitis.
https://gastroenterology.acponline.org/archives/2022/09/23/5.htm
23 Sep 2022
Spotlight on lean NAFLD
Recent studies looked at the increasing prevalence of nonalcoholic fatty liver disease (NAFLD) in patients without overweight or obesity and compared clinical characteristics of these patients with both healthy controls and patients with obesity and NAFLD.
https://gastroenterology.acponline.org/archives/2020/07/24/5.htm
24 Jul 2020
MKSAP Quiz: Hepatocellular carcinoma surveillance after HCV treatment
This month's quiz asks readers to determine the most appropriate biannual surveillance modality for a 62-year-old patient with compensated cirrhosis who was treated for hepatitis C virus (HCV) infection six months ago.
https://gastroenterology.acponline.org/archives/2021/10/22/4.htm
22 Oct 2021
Case reports, series published on gastroenterology, hepatology topics
Recent cases include massive empyema with Edwardsiella tarda in a patient with cirrhosis, paraneoplastic myositis in a patient with extrahepatic cholangiocarcinoma, and two patients with refractory iron deficiency anemia secondary to angiodysplasia-related GI bleeding.
https://gastroenterology.acponline.org/archives/2023/04/21/8.htm
21 Apr 2023
Bariatric surgeries reduced hepatic steatosis in type 2 diabetes at one year
Patients who were randomized to either sleeve gastrectomy or Roux-en-Y gastric bypass showed similar improvements in hepatic steatosis and fibrosis, a randomized trial in Norway found.
https://gastroenterology.acponline.org/archives/2021/12/17/8.htm
17 Dec 2021